The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial
Abstract
Purpose: We investigated the respective contribution (in terms of cancer yield and stage at diagnosis) of clinical breast examination (CBE), mammography, ultrasound, and quality-assured breast magnetic resonance imaging (MRI), used alone or in different combination, for screening women at elevated risk for breast cancer. Methods: Prospective multicenter observational cohort study. Six hundred eighty-seven asymptomatic women at elevated familial risk (≥ 20% lifetime) underwent 1,679 annual screening rounds consisting of CBE, mammography, ultrasound, and MRI, read independently and in different combinations. In a subgroup of 371 women, additional half-yearly ultrasound and CBE was performed more than 869 screening rounds. Mean and median follow-up was 29.18 and 29.09 months. Results: Twenty-seven women were diagnosed with breast cancer: 11 ductal carcinoma in situ (41%) and 16 invasive cancers (59%). Three (11%) of 27 were node positive. All cancers were detected during annual screening; no interval cancer occurred; no cancer was identified during half-yearly ultrasound. The cancer yield of ultrasound (6.0 of 1,000) and mammography (5.4 of 1,000) was equivalent; it increased nonsignificantly (7.7 of 1,000) if both methods were combined. Cancer yield achieved by MRI alone (14.9 of 1,000) was significantly higher; it was not significantly improved by adding mammography (MRI plus mammography: 16.0 of 1,000) and did not change by adding ultrasound (MRI plus ultrasound: 14.9 of 1,000). Positive predictive value was 39% for mammography, 36% for ultrasound, and 48% for MRI. Conclusion: In women at elevated familial risk, quality-assured MRI screening shifts the distribution of screen-detected breast cancers toward the preinvasive stage. In women undergoing quality-assured MRI annually, neither mammography, nor annual or half-yearly ultrasound or CBE will add to the cancer yield achieved by MRI alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Berg, W. A. (2008) · JAMA · doi:10.1001/jama.299.18.2151 · Cited by 1,526
Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.4960 · Cited by 1,147
Self-citationPerry, N., Broeders, M., de Wolf, C., Törnberg, S., Holland, R., & von Karsa, L. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm481 · Cited by 1,020
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2471 · Cited by 911
Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2
Parmigiani, G., Berry, D. A., & Aguilar, O. (1998) · The American Journal of Human Genetics · doi:10.1086/301670 · Cited by 753
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Kuhl, C. K., Schrading, S., Bieling, H. B., Wardelmann, E., Leutner, C. C., Koenig, R., Kuhn, W., & Schild, H. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61232-x · Cited by 711
Self-citationLakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Self-citationLeach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths, J. R., Horsman, M. R., Jackson, A., Jayson, G. C., Judson, I. R., Knopp, M. V., Maxwell, R. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602550 · Cited by 513
Magnetic Resonance Imaging of the Breast Prior to Biopsy
Bluemke, D. A. (2004) · JAMA · doi:10.1001/jama.292.22.2735 · Cited by 513
Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts
Preston, D. L., Mattsson, A., Holmberg, E., Shore, R., Hildreth, N. G., & Boice, J. D. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0220:reobcr]2.0.co;2 · Cited by 512
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., Lerman, C., Watson, P., Lynch, H. T., Hilsenbeck, S. G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.121 · Cited by 505
Jorgensen, K. J., & Gotzsche, P. C. (2009) · BMJ · doi:10.1136/bmj.b2587 · Cited by 502
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., & Jayson, G. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603515 · Cited by 484
Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
Marcus, J. N., Watson, P., Page, D. L., Narod, S. A., Lenoir, G. M., Tonin, P., Linder-Stephenson, L., Salerno, G., Conway, T. A., & Lynch, H. T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w · Cited by 454
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As an Imaging Biomarker
Hylton, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8080 · Cited by 410
U.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
Lehman, C. D., Blume, J. D., Weatherall, P., Thickman, D., Hylton, N., Warner, E., Pisano, E., Schnitt, S. J., Gatsonis, C., Schnall, M., et al. (2005) · Cancer · doi:10.1002/cncr.20971 · Cited by 401
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Sardanelli, F., Podo, F., D'Agnolo, G., Verdecchia, A., Santaquilani, M., Musumeci, R., Trecate, G., Manoukian, S., Morassut, S., de Giacomi, C., et al. (2007) · Radiology · doi:10.1148/radiol.2423051965 · Cited by 339
Performance Benchmarks for Screening Mammography
Rosenberg, R. D., Yankaskas, B. C., Abraham, L. A., Sickles, E. A., Lehman, C. D., Geller, B. M., Carney, P. A., Kerlikowske, K., Buist, D. S. M., Weaver, D. L., et al. (2006) · Radiology · doi:10.1148/radiol.2411051504 · Cited by 336
Brekelmans, C. T. M., Seynaeve, C., Bartels, C. C. M., Tilanus-Linthorst, M. M. A., Meijers-Heijboer, E. J., Crepin, C. M. G., van Geel, A. N., Menke, M., Verhoog, L. C., van den Ouweland, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.924 · Cited by 307
BRCA-associated breast cancer in young women.
Robson, M., Gilewski, T., Haas, B., Levin, D., Borgen, P., Rajan, P., Hirschaut, Y., Pressman, P., Rosen, P. P., Lesser, M. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1642 · Cited by 302
Armes, J. E., Egan, A. J. M., Southey, M. C., Dite, G. S., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Venter, D. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n · Cited by 259
Management of an Inherited Predisposition to Breast Cancer
Robson, M., & Offit, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp071286 · Cited by 252
Shen, Y., Yang, Y., Inoue, L. Y. T., Munsell, M. F., Miller, A. B., & Berry, D. A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji239 · Cited by 249
Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., Ellis, N., Hensley, M., Boyd, J., Borgen, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1260 · Cited by 239
Predicting the survival of patients with breast carcinoma using tumor size
Michaelson, J. S., Silverstein, M., Wyatt, J., Weber, G., Moore, R., Halpern, E., Kopans, D. B., & Hughes, K. (2002) · Cancer · doi:10.1002/cncr.10742 · Cited by 232
Mammographic, US, and MR Imaging Phenotypes of Familial Breast Cancer
Schrading, S., & Kuhl, C. K. (2008) · Radiology · doi:10.1148/radiol.2461062173 · Cited by 227
Self-citationCollett, K., Stefansson, I. M., Eide, J., Braaten, A., Wang, H., Eide, G. E., Thoresen, S. Ø., Foulkes, W. D., & Akslen, L. A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0394 · Cited by 215
German Consortium for Hereditary Breast and Ovarian Cancer (2002) · International Journal of Cancer · doi:10.1002/ijc.1626 · Cited by 205
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Purnomosari, D., Pals, G., Wahyono, A., Aryandono, T., Manuaba, T. W., Haryono, S. J., & van Diest, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9493-4 · Cited by 197
Tilanus‐Linthorst, M., Verhoog, L., Obdeijn, I., Bartels, K., Menke‐Pluymers, M., Eggermont, A., Klijn, J., Meijers‐Heijboer, H., van der Kwast, T., & Brekelmans, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10666 · Cited by 195
Andrieu, N., Easton, D. F., Chang-Claude, J., Rookus, M. A., Brohet, R., Cardis, E., Antoniou, A. C., Wagner, T., Simard, J., Evans, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3126 · Cited by 188
Hagen, A. I., Kvistad, K. A., Maehle, L., Holmen, M. M., Aase, H., Styr, B., Vabø, A., Apold, J., Skaane, P., & Møller, P. (2007) · The Breast · doi:10.1016/j.breast.2007.01.006 · Cited by 175
Wilmes, L. J., Pallavicini, M. G., Fleming, L. M., Gibbs, J., Wang, D., Li, K., Partridge, S. C., Henry, R. G., Shalinsky, D. R., Hu‐Lowe, D. D., et al. (2007) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2006.09.041 · Cited by 157
The effect of tumor size and lymph node status on breast carcinoma lethality
Michaelson, J. S., Silverstein, M. J., Sgroi, D. C., Cheongsiatmoy, J. A., Taghian, A. G., Powell, S. N., Hughes, K. S., Comegno, A., Tanabe, K. K., & Smith, B. (2003) · Cancer · doi:10.1002/cncr.11765 · Cited by 153
Magnetic Resonance Imaging Captures the Biology of Ductal Carcinoma In Situ
Esserman, L. J., Kumar, A. S., Herrera, A. F., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5518 · Cited by 130
Eisinger, F., Alby, N., Bremond, A. G., Dauplat, J., Espié, M., Janiaud, P., Kuttenn, F., Lebrun, J.-P., Lefranc, J.-P., Pierret, J., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008389021382 · Cited by 129
de González, A. B., Berg, C. D., Visvanathan, K., & Robson, M. E. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn440 · Cited by 123
de González, A. B., & REEVES, G. K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602683 · Cited by 115
Tyndel, S., Austoker, J., Henderson, B. J., Brain, K. E., Bankhead, C. R., Clements, A., & Watson, E. K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0437 · Cited by 103
Risk Prediction Models For Familial Breast Cancer
Antoniou, A. C., & Easton, D. F. (2006) · Future Oncology · doi:10.2217/14796694.2.2.257 · Cited by 93
Furman‐Haran, E., Schechtman, E., Kelcz, F., Kirshenbaum, K. J., & Degani, H. (2005) · Cancer · doi:10.1002/cncr.21225 · Cited by 91
Broeks, A., Braaf, L. M., Huseinovic, A., Nooijen, A., Urbanus, J. H. M., Hogervorst, F. B. L., Schmidt, M. K., Klijn, J. G. M., Russell, N. S., van Leeuwen, F. E., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1668 · Cited by 89
Hereditary breast cancer growth rates and its impact on screening policy
Tilanus‐Linthorst, M. M. A., Kriege, M., Boetes, C., Hop, W. C. J., Obdeijn, I.-M., Oosterwijk, J. C., Peterse, H. L., Zonderland, H. M., Meijer, S., Eggermont, A. M. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.034 · Cited by 77
Moasser, M. M., Wilmes, L. J., Wong, C. H., Aliu, S. O., Li, K., Wang, D., Hom, Y. K., Hann, B. C., & Hylton, N. M. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21196 · Cited by 24
Familial Relative Risk Estimates for Use in Epidemiologic Analyses
Yasui, Y., Newcomb, P. A., Trentham‐Dietz, A., & Egan, K. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj256 · Cited by 22
Murday, V. A., Pears, R., Ball, J., Eeles, R. A., & Hodgson, S. V. (2004) · Familial Cancer · doi:10.1023/b:fame.0000026818.34049.84 · Cited by 11
Strahlenrisiko infolge von Mammographie-Screening-Untersuchungen für Frauen unter 50 Jahren
Nekolla, E. A., Griebel, J., & Brix, G. (2008) · Zeitschrift für Medizinische Physik · doi:10.1016/j.zemedi.2007.12.004 · Cited by 6
Cited by
Loibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32381-3 · Cited by 1,648
Kuhl, C. K., Schrading, S., Strobel, K., Schild, H. H., Hilgers, R.-D., & Bieling, H. B. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.5386 · Cited by 679
Self-citationComstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.0572 · Cited by 456
Self-citation25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Alves, F. C., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 420
Self-citation
Metadata
- Authors
- Kuhl, C., Weigel, S., Schrading, S., Arand, B., Bieling, H., König, R., Tombach, B., Leutner, C., Rieber-Brambs, A., Nordhoff, D., Heindel, W., Reiser, M., & Schild, H. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-03-20
- Volume
- 28
- Issue
- 9
- Pages
- 1450-1457
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105213027
- Cited by
- 501
- References
- 56
- FWCI
- 21.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.